|
Indo–Italian experts from India, Italy, Malaysia, and Singapore advised that late detection, misdiagnosis, and gaps in national cancer policy continue to cost young lives and limbs. Sarcomas are often diagnosed late in India, particularly in children, because early signs are frequently overlooked by parents and primary care physicians. Symptoms such as swelling around the knees or shoulders or persistent pain are commonly mistaken for minor injuries, leading to avoidable delays. Population-based cancer registry data reinforce this concern, showing that 68% of Ewing Sarcoma cases occur in the 0–19 age group, with the highest incidence in children aged 10–14 years.
At a meeting convened in Bengaluru for the Indo–Italian Consensus Meet on Sarcoma and Complex Orthopaedic Reconstruction, organised by the Global Healthcare Academy, focused on paediatric/adult sarcoma care, complex reconstructions, 3D printing, regenerative medicine, and precision orthopaedic oncology via expert panels and hands-on workshops.
Dr B S Ajai Kumar, founder & chairman, HealthCare Global Enterprises Ltd said that “Sarcomas are preventable when diagnosed early and treated the right way, the first time. The Indo-Italian Consensus Meet marks an important milestone in bringing together global expertise to complement and strengthen our standards of care. By increasing awareness, ensuring rapid access to MRI, and establishing a national Sarcoma Registry, we can enable timely diagnosis, higher limb-salvage rates, and equitable care for patients across India - whether they live in Bengaluru or in a small rural town.
The central goal in sarcoma management is to prevent recurrence. This is only possible when every patient - child or adult - receives evidence-based, multidisciplinary, first-time-right treatment. Over several decades, HCG has built one of the largest sarcoma programs in the country, he added.
Parents are advised to watch for red flags such as persistent bone pain for weeks, night pain, a growing lump or swelling, limping or reduced mobility, fractures from minor injuries, and unexplained fever, weight loss, or fatigue. These symptoms warrant immediate medical evaluation.
Dr. Pramod Chinder, orthopaedic surgeon and group director – orthopaedic oncology, HCG Cancer Centre, said: “The biggest tragedy in sarcoma care is when a child loses a limb simply because the first surgery was not done right. Early MRI, correct biopsy, and a multidisciplinary approach are non-negotiable. Our collaboration with leaders from the Rizzoli Orthopaedic Institute, Italy, brings world-class limb-salvage techniques, 3D-printed implants, and precision navigation to Indian practice.”
In India, cancers affecting the bones and muscles make up only about 1% of all cancers, making them among the rarest forms; yet they are nearly 70% curable when diagnosed early and treated appropriately, especially in children.
The conference marks a step toward developing an organized Sarcoma Registry for India, a crucial requirement in today’s AI-driven healthcare era, where accurate data and precision-guided care can significantly improve survival outcomes.
The meet highlighted advanced technologies transforming sarcoma care, including robotic navigation, 3D-printed implants, targeted chemotherapy, and image-guided minimally invasive treatments, supported by genomics and immunotherapy, improving limb-salvage success. Despite being highly treatable when diagnosed early, sarcomas remain excluded from most public health schemes, leaving families with significant financial burdens. Experts called for insurance coverage, wider MRI access, regional referral centres, and a mandatory national Sarcoma Registry to improve timely, equitable care.
|